Stable patients with schizophrenia switched to paliperidone palmitate 3-monthly formulation in a naturalistic setting: impact of patient age and disease duration on outcomes.
Katalin PungorVasilis P BozikasRobin EmsleyPierre Michel LlorcaSrihari GopalMaju MathewsAnnette WoollerPaul BergmansPublished in: Therapeutic advances in psychopharmacology (2020)
NCT02713282.